Baxter InternationalMEX:BAX 44 Days Payable is 52.52 as of Mar. 2026, which is 2% above its 10-year median of 51.68. GuruFocus rates MEX:BAX with a GF Score™ of 44/100 and a GF Value™ of MXN575.93 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Baxter International ranks worse than 69.85% on this metric.
The historical rank and industry rank for Baxter International's Days Payable or its related term are showing as below:
MEX:BAX'
s Days Payable Range Over the Past 10 Years
Min: 45.48 Med: 51.68 Max: 66.07
Current: 46.1
During the past 13 years, Baxter International's highest Days Payable was 66.07. The lowest was 45.48. And the median was 51.68.
MEX:BAX's Days Payable is ranked worse than 69.85% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs MEX:BAX: 46.10
Baxter International's Days Payable
increased
from Mar. 2025 (50.43) to Mar. 2026 (52.52).
It may suggest that Baxter Internationaldelayed paying its suppliers.
Baxter International Days Payable Related Terms
Baxter International Days Payable Historical Data
* Premium members only.
The historical data trend for Baxter International's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:BAX vs COO, ATR, RGEN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Days Payable distribution charts can be found below:
* The bar in red indicates where Baxter International's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Baxter International's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (MEX:BAX) has a Days Payable of 52.52 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Baxter International and its competitors. This is near median its historical median of 51.68. Over the past decade, Baxter International's Days Payable has ranged from 45.48 to 66.07. According to the industry distribution chart, Baxter International ranks #556 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 69.8%.
Is Baxter International's Days Payable too high?
Baxter International's current Days Payable of 52.52 is near median its 10-year median of 51.68. Over the past 10 years, this metric has ranged from a low of 45.48 to a high of 66.07. The Medical Devices & Instruments industry median Days Payable is 68.14. Baxter International's value of 52.52 is 22.9% below this industry median. Based on the distribution chart, Baxter International ranks #556 out of 796 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Baxter International has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Days Payable compare to COO and ATR?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #556 out of 796 companies for Days Payable. This places Baxter International in the lower half of its industry. The industry median Days Payable is 68.14. Baxter International's value of 52.52 is 22.9% below this benchmark. Historically, Baxter International's own Days Payable has ranged from 45.48 to 66.07 over the past decade. While the company's 10-year median is 51.68 vs. the industry median of 68.14, Baxter International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baxter International's current Days Payable of 52.52 is 22.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Baxter International and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current Days Payable is 52.52, which is near median its own 10-year median of 51.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (MEX:BAX) is currently considered Possible Value Trap. The stock's GF Value™ is MXN575.93, compared to a current price of MXN368.89 — trading 35.9% below its estimated fair value. The current Days Payable is 52.52, which is near median its 10-year median of 51.68 and 22.9% below the Medical Devices & Instruments industry median of 68.14. Baxter International's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Baxter International (MEX:BAX), the current Days Payable is 52.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (MEX:BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of MXN368.89 is trading 35.9% below its estimated GF Value™ of MXN575.93.
GuruFocus considers Baxter International to be Possible Value Trap.
Key valuation signals for MEX:BAX:
Days Payable: 52.52 (near median its 10-year median of 51.68)
GF Value™: MXN575.93 vs. price of MXN368.89 (35.9% below fair value)
Industry Position: 22.9% below the Medical Devices & Instruments median (#556 of 796)
No single metric tells the full story. See the MEX:BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
44GF Score
Get the complete analysis for MEX:BAX
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BAX has been successfully added to your 
